世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ターゲットシーケンスとリシーケンスの世界市場規模調査&予測、技術別(シーケンス、リシーケンス)、タイプ別(DNA、RNA)、用途別(臨床応用、植物・動物科学、医薬品開発、その他)、最終用途別(病院・診療所、学術研究、その他)と地域分析、2022-2029年


Global Targeted Sequencing and Resequencing Market Size study & Forecast, by Technology (Sequencing, Resequencing) by Type (DNA, RNA), by Application (Clinical Application, Plant & animal sciences, Drug development, Others), by End-use (Hospitals & clinics, Academic Research, Others) and Regional Analysis, 2022-2029

世界のTargeted SequencingおよびResequencing市場は、2021年に約41億米ドルと評価され、予測期間2022-2029年に22.59%以上の健全な成長率で成長すると予測されています。Targeted Sequencingは、特定の遺伝子セッ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2023年3月20日 US$4,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
200 英語

 

サマリー

世界のTargeted SequencingおよびResequencing市場は、2021年に約41億米ドルと評価され、予測期間2022-2029年に22.59%以上の健全な成長率で成長すると予測されています。Targeted Sequencingは、特定の遺伝子セットにおける異常な変異を検出する方法であり、Resequencingは、遺伝子のサブセットを分離して配列決定する方法である。Targeted SequencingとResequencingは、ある人のゲノムの一部をシーケンスして、その人とその種の典型的なゲノムとの間の配列の不一致を探すために用いられる方法である。ショットガンとハイスループットが、DNAシーケンスの2大タイプです。ターゲットシーケンスやリシーケンスは、様々な先天性疾患に起因するDNAの変異を検出するために使用されます。WGSなどの調査方法と比較して、結果の適切な解析が可能であり、シーケンスデータの誤った解釈を防ぐことができます。フルゲノムシーケンスのコスト削減メリット、製薬業界における研究開発投資の増加、アンプリコンシーケンスと標的遺伝子パネルのメリット、シーケンス技術の技術的進歩が、主要な市場成長の要因となっています。

国立医学図書館によると、フルゲノムシーケンスの費用は2007年で約1000万円。その後、シーケンスの価格は急速に低下し、1000ドルゲノムの実現も近いと予想されています。さらに、2019年、医薬品事業における研究開発費は830億ドルでした。特に、2015年から2019年にかけて、医薬品の研究開発への投資額は約50%急増しました。研究開発投資の増加は、革新的なSequencingおよびResequencing技術の開発につながります。フルゲノムシーケンスのコスト削減の利点と、製薬業界における研究開発投資の増加は、市場の成長を促進する主な要因です。その他、アンプリコンシーケンスや標的遺伝子パネルの利点、シーケンシング技術の技術的進歩も市場拡大を促進する要素です。さらに、デジタル次世代シーケンサー技術の出現と、より短時間でシーケンサーを実行するための進歩は、予測期間中に大きな市場機会を生み出す要因となっています。しかし、ターゲットシーケンスとリシーケンスを維持するための高いコストが、2022年から2029年の予測期間を通じて市場の成長を阻害します。

Targeted Sequencing And Resequencingの世界市場調査において考慮した主要地域は、アジア太平洋、北米、ヨーロッパ、ラテンアメリカ、およびその他の地域です。北米は、市場プレイヤーの優位性、技術の進歩の増加、同地域のシーケンス能力の開発の増加により、収益面で市場を支配しています。アジア太平洋地域は、研究開発への投資の増加、医薬品開発・発見のための先端技術の普及、主要プレイヤーの地域的拡大などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。
本レポートに含まれる主な市場プレイヤーは以下の通りです:
イルミナ(Illumina, Inc.
F.Hoffmann-La Roche Ltd.
アジレント・テクノロジー株式会社(Agilent Technologies Inc.
GATC Biotech Ag
オックスフォード・ナノポア・テクノロジーズ
サーモフィッシャーサイエンティフィック株式会社
DNASTAR Inc.
QIAGEN
BGI
パーキンエルマー社(Perkin Elmer, Inc.
市場における最近の動向:
 2021年1月、イルミナは、プレシジョンオンコロジーのための標準化された広く利用可能なツールを作成するという同社の目標をサポートする、メルク、ミリアドジェネティクス、クラオンコロジー、ブリストル・マイヤーズスクイブの複数の協業を発表しました。
 2022年8月、The Medical Device Innovation Consortium(MDIC)は、公開ゲノムデータセットと治療関連サンプルの検証および開発により、NGSベースのがん診断を改善する取り組み、Somatic Reference Samples(SRS)を発表しました。
世界のTargeted Sequencing And Resequencing市場レポートスコープ:
ヒストリカルデータ2019-2020-2021
推計基準年 2021年
予測期間 2022-2029
レポート対象 売上高予測、企業ランキング、競合状況、成長要因、トレンド
対象分野 技術, タイプ, アプリケーション, エンドユース, 地域
地域区分 北米、欧州、アジア太平洋、中南米、その他の地域
カスタマイズ範囲 レポート購入時に無料カスタマイズ(アナリストの作業時間8時間分まで)。国別、地域別、セグメント別スコープの追加・変更*。

本調査の目的は、近年における様々なセグメントおよび国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国において、業界の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する推進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と技術提供の詳細な分析とともに、関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します:
技術別
シーケンサー
リシーケンス

タイプ別
DNA
RNA

用途別に見る
クリニカルアプリケーション
植物・動物科学
医薬品開発
その他

エンドユーズ別
病院・診療所
学術研究
その他


地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
連邦王国
ドイツ
フランス
スペイン
イタリア
ROE
アジア太平洋
中国
インド
日本
オーストラリア
南朝鮮
ロアパック
ラテンアメリカ
ブラジル
メキシコ
その他の地域

ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Targeted Sequencing And Resequencing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Targeted Sequencing And Resequencing Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Targeted Sequencing And Resequencing Market, by Type, 2019-2029 (USD Billion)
1.2.4. Targeted Sequencing And Resequencing Market, by Application, 2019-2029 (USD Billion)
1.2.5. Targeted Sequencing And Resequencing Market, by End-use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Targeted Sequencing and Resequencing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Targeted Sequencing and Resequencing Market Dynamics
3.1. Targeted Sequencing and Resequencing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Decreasing cost of full genome sequencing
3.1.1.2. increasing R&D investments in the pharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. High Cost of maintaining Targeted Sequencing and Resequencing technology
3.1.3. Market Opportunities
3.1.3.1. Emerging digital next-generation sequencing technology
3.1.3.2. Advancements to perform sequencing in less time.
Chapter 4. Global Targeted Sequencing and Resequencing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Targeted Sequencing And Resequencing Market, by Technology
6.1. Market Snapshot
6.2. Global Targeted Sequencing And Resequencing Market by Technology, Performance - Potential Analysis
6.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
6.4.1. Sequencing
6.4.2. Re-sequencing
Chapter 7. Global Targeted Sequencing And Resequencing Market, by Type
7.1. Market Snapshot
7.2. Global Targeted Sequencing And Resequencing Market by Type, Performance - Potential Analysis
7.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
7.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
7.4.1. DNA
7.4.2. RNA
Chapter 8. Global Targeted Sequencing And Resequencing Market, by Application
8.1. Market Snapshot
8.2. Global Targeted Sequencing And Resequencing Market by Application, Performance - Potential Analysis
8.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
8.4.1. Clinical Application
8.4.2. Plant & animal sciences
8.4.3. Drug development
8.4.4. Oyhers
Chapter 9. Global Targeted Sequencing And Resequencing Market, by End-use
9.1. Market Snapshot
9.2. Global Targeted Sequencing And Resequencing Market by End-use, Performance - Potential Analysis
9.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
9.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
9.4.1. Hospitals & Clinics
9.4.2. Academic ResearchOthers
Chapter 10. Global Targeted Sequencing And Resequencing Market, Regional Analysis
10.1. Targeted Sequencing And Resequencing Market, Regional Market Snapshot
10.2. North America Targeted Sequencing And Resequencing Market
10.2.1. U.S. Targeted Sequencing And Resequencing Market
10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.2. Type breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. End-use breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Targeted Sequencing And Resequencing Market
10.3. Europe Targeted Sequencing And Resequencing Market Snapshot
10.3.1. U.K. Targeted Sequencing And Resequencing Market
10.3.2. Germany Targeted Sequencing And Resequencing Market
10.3.3. France Targeted Sequencing And Resequencing Market
10.3.4. Spain Targeted Sequencing And Resequencing Market
10.3.5. Italy Targeted Sequencing And Resequencing Market
10.3.6. Rest of Europe Targeted Sequencing And Resequencing Market
10.4. Asia-Pacific Targeted Sequencing And Resequencing Market Snapshot
10.4.1. China Targeted Sequencing And Resequencing Market
10.4.2. India Targeted Sequencing And Resequencing Market
10.4.3. Japan Targeted Sequencing And Resequencing Market
10.4.4. Australia Targeted Sequencing And Resequencing Market
10.4.5. South Korea Targeted Sequencing And Resequencing Market
10.4.6. Rest of Asia Pacific Targeted Sequencing And Resequencing Market
10.5. Latin America Targeted Sequencing And Resequencing Market Snapshot
10.5.1. Brazil Targeted Sequencing And Resequencing Market
10.5.2. Mexico Targeted Sequencing And Resequencing Market
10.6. Rest of The World Targeted Sequencing And Resequencing Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Illumina, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. F. Hoffmann-La Roche Ltd
11.2.3. Agilent Technologies Inc.
11.2.4. GATC Biotech Ag
11.2.5. Oxford Nanopore Technologies
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. DNASTAR Inc.
11.2.8. QIAGEN
11.2.9. BGI
11.2.10. Perkin Elmer, Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

 

ページTOPに戻る


 

Summary

Global Targeted Sequencing and Resequencing Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 22.59% over the forecast period 2022-2029. Targeted Sequencing is a method of detecting unusual variants in a certain set of genes whereas, Resequencing is a method in which a subset of genes is isolated and sequenced. Targeted Sequencing and Resequencing are the methods used for the sequencing of a portion of a person's genome to look for sequence discrepancies between that person and the species' typical genome. Shotgun and high throughput are the two main types of DNA sequencing. Targeted sequencing and resequencing are used for the detection of mutations in DNA caused by various congenital diseases. In comparison to WGS and other survey methods, it provides a proper analysis of the results and prevents the erroneous interpretation of sequencing data. Cost-saving advantages of full genome sequencing, increasing R&D investments in the pharmaceutical industry, advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology are the factors driving the major market growth.

According to the National Library of Medicine, full genome sequencing costs about $10 million in 2007. Since then, sequencing prices have decreased rapidly, and it is expected that the $1000 genome will soon become a reality. Additionally, in 2019, R&D expenditures in the pharmaceutical business were $83 billion. Particularly, between 2015 and 2019, investment in pharmaceutical R&D surged by about 50%. Increasing R&D investments leads to the development of innovative Sequencing and Resequencing techniques. Cost-saving advantages of full genome sequencing and increasing research and development investments in the pharmaceutical industry are the major factors driving the growth of the market. Other components driving market increase are the advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology. Furthermore, emerging digital next-generation sequencing technology and advancements to perform sequencing in less time are the factors creating major market opportunities in the forecast period. However, the high cost of maintaining Targeted Sequencing and Resequencing stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Targeted Sequencing And Resequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of market players, increasing advancements in technology, and the region's increasing development of sequencing capabilities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing investments in research & development, the prevalence of advanced technology for drug development and discovery, and the geographic expansion of key players.
Major market player included in this report are:
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies Inc.
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Recent Developments in the Market:
 In January 2021, Illumina announced several collaborations between Merck, Myriad Genetics, Kura Oncology, and Bristol Myers Squibb that support the company's goal of creating standardized, widely available tools for precision oncology.
 In Aug 2022, The Medical Device Innovation Consortium (MDIC) introduced Somatic Reference Samples (SRS), an initiative to improve NGS-based cancer diagnosis by validating and developing public genomic datasets and therapeutically relevant samples.
Global Targeted Sequencing And Resequencing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Type, Application, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Sequencing
Re-sequencing

By Type:
DNA
RNA

By Application:
Clinical Application
Plant & animal sciences
Drug development
Others

By End-use:
Hospitals & clinics
Academic Research
Others


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World



ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Targeted Sequencing And Resequencing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Targeted Sequencing And Resequencing Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Targeted Sequencing And Resequencing Market, by Type, 2019-2029 (USD Billion)
1.2.4. Targeted Sequencing And Resequencing Market, by Application, 2019-2029 (USD Billion)
1.2.5. Targeted Sequencing And Resequencing Market, by End-use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Targeted Sequencing and Resequencing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Targeted Sequencing and Resequencing Market Dynamics
3.1. Targeted Sequencing and Resequencing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Decreasing cost of full genome sequencing
3.1.1.2. increasing R&D investments in the pharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. High Cost of maintaining Targeted Sequencing and Resequencing technology
3.1.3. Market Opportunities
3.1.3.1. Emerging digital next-generation sequencing technology
3.1.3.2. Advancements to perform sequencing in less time.
Chapter 4. Global Targeted Sequencing and Resequencing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Targeted Sequencing And Resequencing Market, by Technology
6.1. Market Snapshot
6.2. Global Targeted Sequencing And Resequencing Market by Technology, Performance - Potential Analysis
6.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
6.4.1. Sequencing
6.4.2. Re-sequencing
Chapter 7. Global Targeted Sequencing And Resequencing Market, by Type
7.1. Market Snapshot
7.2. Global Targeted Sequencing And Resequencing Market by Type, Performance - Potential Analysis
7.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
7.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
7.4.1. DNA
7.4.2. RNA
Chapter 8. Global Targeted Sequencing And Resequencing Market, by Application
8.1. Market Snapshot
8.2. Global Targeted Sequencing And Resequencing Market by Application, Performance - Potential Analysis
8.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
8.4.1. Clinical Application
8.4.2. Plant & animal sciences
8.4.3. Drug development
8.4.4. Oyhers
Chapter 9. Global Targeted Sequencing And Resequencing Market, by End-use
9.1. Market Snapshot
9.2. Global Targeted Sequencing And Resequencing Market by End-use, Performance - Potential Analysis
9.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
9.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
9.4.1. Hospitals & Clinics
9.4.2. Academic ResearchOthers
Chapter 10. Global Targeted Sequencing And Resequencing Market, Regional Analysis
10.1. Targeted Sequencing And Resequencing Market, Regional Market Snapshot
10.2. North America Targeted Sequencing And Resequencing Market
10.2.1. U.S. Targeted Sequencing And Resequencing Market
10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.2. Type breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. End-use breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Targeted Sequencing And Resequencing Market
10.3. Europe Targeted Sequencing And Resequencing Market Snapshot
10.3.1. U.K. Targeted Sequencing And Resequencing Market
10.3.2. Germany Targeted Sequencing And Resequencing Market
10.3.3. France Targeted Sequencing And Resequencing Market
10.3.4. Spain Targeted Sequencing And Resequencing Market
10.3.5. Italy Targeted Sequencing And Resequencing Market
10.3.6. Rest of Europe Targeted Sequencing And Resequencing Market
10.4. Asia-Pacific Targeted Sequencing And Resequencing Market Snapshot
10.4.1. China Targeted Sequencing And Resequencing Market
10.4.2. India Targeted Sequencing And Resequencing Market
10.4.3. Japan Targeted Sequencing And Resequencing Market
10.4.4. Australia Targeted Sequencing And Resequencing Market
10.4.5. South Korea Targeted Sequencing And Resequencing Market
10.4.6. Rest of Asia Pacific Targeted Sequencing And Resequencing Market
10.5. Latin America Targeted Sequencing And Resequencing Market Snapshot
10.5.1. Brazil Targeted Sequencing And Resequencing Market
10.5.2. Mexico Targeted Sequencing And Resequencing Market
10.6. Rest of The World Targeted Sequencing And Resequencing Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Illumina, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. F. Hoffmann-La Roche Ltd
11.2.3. Agilent Technologies Inc.
11.2.4. GATC Biotech Ag
11.2.5. Oxford Nanopore Technologies
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. DNASTAR Inc.
11.2.8. QIAGEN
11.2.9. BGI
11.2.10. Perkin Elmer, Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

Bizwit Research & Consulting LLP社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD(dna)の最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る